BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Genetown

  Abiomed to Present at Morgan Stanley Global Healthcare Conference

  September 3, 2013

   · 

  1 min read
• Business

  Champions Oncology, Inc. Announces Two Additions to Senior Management Team

  September 3, 2013

   · 

  1 min read
• BioMidwest

  Stereotaxis, Inc. Announces Renewal of Silicon Valley Bank Credit Facility

  September 3, 2013

   · 

  1 min read
• JPK Instruments AG Reports on the Studies of the Nanomechanical Properties of Biomaterials at Nagoya Institute of Technology in Japan

  September 3, 2013

   · 

  3 min read
• Business

  OncoMed Pharmaceuticals, Inc. Announces Second Quarter 2013 Financial Results

  September 3, 2013

   · 

  1 min read
• LEUKOCARE Announces EUR 3.4 Million Capital Increase

  September 3, 2013

   · 

  2 min read
• Business

  Sigma(R) Life Science Licenses CompoZr Zinc Finger Nuclease Technology to Horizon Discovery Ltd.

  September 3, 2013

   · 

  4 min read
• BioLineRx Ltd. Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells

  September 3, 2013

   · 

  5 min read
• Drug Development

  Esperion Therapeutics, Inc. Announces Positive Results From Phase 2a Study of ETC-1002

  September 3, 2013

   · 

  6 min read
• Drug Development

  Bristol-Myers Squibb Company Release: New Eliquis® (apixaban) Post-Hoc Subanalysis of the Phase III ARISTOTLE Trial Demonstrated That Within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding Were Uncommon

  September 3, 2013

   · 

  14 min read